We are live on ! Find out more
AGA

Altrinsic Global Advisors Portfolio holdings

AUM $2.79B
1-Year Est. Return 7.25%
This Fund
S&P 500
This Quarter Est. Return
+4.38%
1 Year Est. Return
+7.25%
3 Year Est. Return
+44.27%
5 Year Est. Return
+55.25%
10 Year Est. Return
+173.46%
AUM
$3.58B
AUM Growth
-$276M
Cap. Flow
-$391M
Cap. Flow %
-10.94%
Top 10 Hldgs %
41.17%
Holding
90
New
5
Increased
17
Reduced
48
Closed
6

Top Buys

Rank Stock Value
1
AIZ icon
Assurant
AIZ
+$32.1M
2
BIIB icon
Biogen
BIIB
+$29.4M
3
SABR icon
Sabre
SABR
+$28.1M
4
TGT icon
Target
TGT
+$23.7M
5
PYPL icon
PayPal
PYPL
+$21.8M

Sector Composition

Rank Sector Weight
1 Financials 30.79%
2 Communication Services 19.04%
3 Healthcare 11.57%
4 Consumer Staples 10.87%
5 Energy 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAC
51
DELISTED
AAC Holdings
AAC
$9.98M 0.28%
504,370
BSX icon
52
Boston Scientific
BSX
$68.5B
$9.96M 0.28%
529,700
-100,000
-16% -$1.76M
NXTM
53
DELISTED
NxStage Medical Inc.
NXTM
$9.39M 0.26%
626,300
-100,000
-14% -$1.68M
BMRN icon
54
BioMarin Pharmaceuticals
BMRN
$12B
$7.03M 0.2%
85,168
KND
55
DELISTED
Kindred Healthcare
KND
$6.51M 0.18%
527,000
+100,000
+23% +$1.04M
RAD
56
DELISTED
Rite Aid Corporation
RAD
$6.25M 0.17%
38,375
MMSI icon
57
Merit Medical Systems
MMSI
$4.67B
$6.16M 0.17%
333,000
PODD icon
58
Insulet
PODD
$11.6B
$5M 0.14%
150,900
NVDQ
59
DELISTED
Novadaq Technologies Inc.
NVDQ
$4.89M 0.14%
441,100
+5,000
+1% +$52.9K
ELGX
60
DELISTED
Endologix Inc
ELGX
$4.85M 0.14%
58,000
+5,000
+9% +$412K
CBPO
61
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$4.79M 0.13%
41,858
-3,100
-7% -$364K
SNDA icon
62
Sonida Senior Living
SNDA
$2.04B
$4.74M 0.13%
17,067
BKD icon
63
Brookdale Senior Living
BKD
$3.67B
$4.64M 0.13%
292,452
+50,000
+21% +$763K
SPNE
64
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$4.32M 0.12%
295,300
ALNY icon
65
Alnylam Pharmaceuticals
ALNY
$38.5B
$4.25M 0.12%
+67,700
New +$4.5M
SGNT
66
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$4.03M 0.11%
331,100
DVCR
67
DELISTED
Diversicare Healthcare Services Inc
DVCR
$3.77M 0.11%
443,952
NSTG
68
DELISTED
NanoString Technologies, Inc.
NSTG
$3.49M 0.1%
229,211
+12,500
+6% +$177K
SGMO
69
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3.02M 0.08%
500,000
+10,000
+2% +$60K
AGTC
70
DELISTED
Applied Genetic Technologies Corporation
AGTC
$2.78M 0.08%
199,000
XNPT
71
DELISTED
XENOPORT, INC.
XNPT
$2.74M 0.08%
606,645
BABA icon
72
Alibaba
BABA
$276B
$1.72M 0.05%
21,776
-6,106
-22% -$430K
TSM icon
73
TSMC
TSM
$2.03T
$1.68M 0.05%
63,996
-23,751
-27% -$556K
ARGS
74
DELISTED
Argos Therapeutics, Inc.
ARGS
$1.1M 0.03%
8,625
-2,000
-19% -$162K
TEAR
75
DELISTED
TearLab Corporation
TEAR
$1.06M 0.03%
168,510

Similar funds

Altrinsic Global Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Altrinsic Global Advisors held 90 positions worth $3.58B, down 7.2% from $3.85B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Altrinsic Global Advisors withdrew a net $391M in Q1 2016, closing 6 positions and reducing 48 holdings. Its most notable exit was Willis Towers Watson, an estimated $249M position sold in full.

By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 34% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Altrinsic Global Advisors opened a new position in Assurant worth $32.7M.

  • Altrinsic Global Advisors's largest Q1 2016 buy was Assurant: 423,519 shares worth $32.7M.
  • Altrinsic Global Advisors added most to Target in Q1 2016, an estimated $23.7M increase.
  • Altrinsic Global Advisors's biggest Q1 2016 reduction was BAXALTA INC COM STK (DE), cutting an estimated $64.9M.
  • Altrinsic Global Advisors fully exited Willis Towers Watson in Q1 2016, selling an estimated $249M.
  • Altrinsic Global Advisors's ten largest holdings make up 41% of its $3.58B portfolio in Q1 2016.
  • Altrinsic Global Advisors opened 5 new positions and closed 6 in Q1 2016.
  • Altrinsic Global Advisors's portfolio value fell 7.2% quarter-over-quarter to $3.58B.

Based on Altrinsic Global Advisors's 13F filing for Q1 2016, filed 13 May 2016.